No Data
No Data
S&P 500 Futures Climb In Premarket Trading; Tempus AI, IDACORP Lead
Ionis Pharmaceuticals Insider Sold Shares Worth $1,091,444, According to a Recent SEC Filing
Insider Sale: EVP Research of $IONS (IONS) Sells 7,154 Shares
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock With Biggest Upside Potential
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Ionis Pharmaceuticals (IONS) Gets a Hold From Bernstein